Citations for
1PRDM16, REST, SRCAP
The chromatin remodeler SRCAP promotes self-renewal of intestinal stem cells.
Ye B, Yang L, Qian G, Liu B, Zhu X, Zhu P, Ma J, Xie W, Li H, Lu T, Wang Y, Wang S, Du Y, Wang Z, Jiang J, Li J, Fan D, Meng S, Wu J, Tian Y, Fan Z.
EMBO J. Jul 1;39(13):e103786. doi: 10.15252/embj.2019103786. Epub 2020 May 25 2020
2MECOM, PRDM16
Prdm3 and Prdm16 cooperatively maintain hematopoiesis and clonogenic potential.
McGlynn KA, Sun R, Vonica A, Rudzinskas S, Zhang Y, Perkins AS.
Exp Hematol. May;85:20-32.e3. doi: 10.1016/j.exphem.2020.04.010. Epub 2020 May 11. 2020
3MED1, PRDM16, UCP1
PRDM16 enhances nuclear receptor-dependent transcription of the brown fat-specific Ucp1 gene through interactions with Mediator subunit MED1.
Iida S, Chen W, Nakadai T, Ohkuma Y, Roeder RG.
Genes Dev 29(3):308-21. doi: 10.1101/gad.252809.114. 2015
4MED1, PRDM16
PRDM16 binds MED1 and controls chromatin architecture to determine a brown fat transcriptional program.
Harms MJ, Lim HW, Ho Y, Shapira SN, Ishibashi J, Rajakumari S, Steger DJ, Lazar MA, Won KJ, Seale P.
Genes Dev 29(3):298-307. doi: 10.1101/gad.252734.114. 2015
5PRDM16
Prdm16 is required for the maintenance of brown adipocyte identity and function in adult mice.
Harms MJ, Ishibashi J, Wang W, Lim HW, Goyama S, Sato T, Kurokawa M, Won KJ, Seale P.
Cell Metab 19(4):593-604. doi: 10.1016/j.cmet.2014.03.007. 2014
6LVNC8, PRDM16
Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy.
Arndt AK, Schafer S, Drenckhahn JD, Sabeh MK, Plovie ER, Caliebe A, Klopocki E, Musso G, Werdich AA, Kalwa H, Heinig M, Padera RF, Wassilew K, Bluhm J, Harnack C, Martitz J, Barton PJ, Greutmann M, Berger F, Hubner N, Siebert R, Kramer HH, Cook SA, MacRae CA, Klaassen S.
Am J Hum Genet 93(1):67-77. doi: 10.1016/j.ajhg.2013.05.015. Epub 2013 Jun 13. 2013
7EHMT1, PRDM16
EHMT1 controls brown adipose cell fate and thermogenesis through the PRDM16 complex.
Ohno H, Shinoda K, Ohyama K, Sharp LZ, Kajimura S.
Nature 504(7478):163-7. doi: 10.1038/nature12652. 2013
8IGF2, MYOD1, PRDM16
Double Myod and Igf2 inactivation promotes brown adipose tissue development by increasing Prdm16 expression.
Borensztein M, Viengchareun S, Montarras D, Journot L, Binart N, Lombès M, Dandolo L.
FASEB J 26(11):4584-91. doi: 10.1096/fj.12-208496. Epub 2012 Aug 2. 2012
9MECOM, PRDM16, SUV39H1
Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity.
Pinheiro I, Margueron R, Shukeir N, Eisold M, Fritzsch C, Richter FM, Mittler G, Genoud C, Goyama S, Kurokawa M, Son J, Reinberg D, Lachner M, Jenuwein T.
Cell 150(5):948-60. doi: 10.1016/j.cell.2012.06.048. 2012
10IGF2, MYOD1, PRDM16, UCP1
Double Myod and Igf2 inactivation promotes brown adipose tissue development by increasing Prdm16 expression.
Borensztein M, Viengchareun S, Montarras D, Journot L, Binart N, Lombès M, Dandolo L.
FASEB J 26(11):4584-91. doi: 10.1096/fj.12-208496. Epub 2012 Aug 2. 2012
11PRDM16
Prdm16 is a physiological regulator of hematopoietic stem cells.
Aguilo F, Avagyan S, Labar AS, Sevilla A, Lee DF, Kumar P, Lemischka IR, Zhou BY, Snoeck HW.
Blood lood. 2011 Feb 22. [Epub ahead of print] 2011
12HGF, PRDM16
Prdm16 promotes stem cell maintenance in multiple tissues, partly by regulating oxidative stress.
Chuikov S, Levi BP, Smith ML, Morrison SJ.
Nat Cell Biol 12(10):999-1006. Epub 2010 Sep 12. 2010
13PRDM16
Prdm16 is required for normal palatogenesis in mice.
Bjork BC, Turbe-Doan A, Prysak M, Herron BJ, Beier DR.
Hum Mol Genet 19(5):774-89. Epub 2009 Dec 11. 2010
14PRDM16, SKI
SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells.
Takahata M, Inoue Y, Tsuda H, Imoto I, Koinuma D, Hayashi M, Ichikura T, Yamori T, Nagasaki K, Yoshida M, Matsuoka M, Morishita K, Yuki K, Hanyu A, Miyazawa K, Inazawa J, Miyazono K, Imamura T.
J Biol Chem 284(5):3334-44. Epub 2008 Dec 1. 2009
15PRDM16
PRDM16: the interconvertible adipo-myocyte switch.
Frühbeck G, Sesma P, Burrell MA.
Trends Cell Biol 19(4):141-6. Epub 2009 Mar 13. 2009
16BMP7, PRDM16, UCP1
New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure.
Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, Taniguchi CM, Tran TT, Suzuki R, Espinoza DO, Yamamoto Y, Ahrens MJ, Dudley AT, Norris AW, Kulkarni RN, Kahn CR.
Nature 454(7207):1000-4. 2008
17PRDM16
PRDM16 controls a brown fat/skeletal muscle switch.
Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, Scimè A, Devarakonda S, Conroe HM, Erdjument-Bromage H, Tempst P, Rudnicki MA, Beier DR, Spiegelman BM.
Nature 454(7207):961-7. 2008
18PRDM16
Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex.
Kajimura S, Seale P, Tomaru T, Erdjument-Bromage H, Cooper MP, Ruas JL, Chin S, Tempst P, Lazar MA, Spiegelman BM.
Genes Dev 22(10):1397-409. 2008
19PRDM16, RUNX1
Identification of truncated RUNX1 and RUNX1-PRDM16 fusion transcripts in a case of t(1;21)(p36;q22)-positive therapy-related AML.
Stevens-Kroef MJ, Schoenmakers EF, van Kraaij M, Huys E, Vermeulen S, van der Reijden B, van Kessel AG.
Leukemia 20(6):1187-9. No abstract available. 2006
20RUNX1, PRDM16
Overexpression of PRDM16 in the presence and absence of the RUNX1/PRDM16 fusion gene in myeloid leukemias.
Hazourli S, Chagnon P, Sauvageau M, Fetni R, Busque L, Hebert J.
Genes Chromosomes Cancer 45(11):1072-6. No abstract available. 2006
21PRDM16
MEL1S, not MEL1, is overexpressed in myelodysplastic syndromes patients with t(1;3)(p36;q21).
Xiao Z, Zhang M, Liu X, Zhang Y, Yang L, Hao Y.
Leuk Res 30(3):332-4. Epub 2005 Aug 15. 2006
22RUNX1, PRDM16
Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22).
Sakai I, Tamura T, Narumi H, Uchida N, Yakushijin Y, Hato T, Fujita S, Yasukawa M.
Genes Chromosomes Cancer 44(3):265-70. 2005
23MDS1, MECOM, PRDM16
Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells.
Lahortiga I, Agirre X, Belloni E, Vazquez I, Larrayoz MJ, Gasparini P, Lo Coco F, Pelicci PG, Calasanz MJ, Odero MD.
Oncogene 23(1):311-6. 2004
24PRDM16
Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells.
Yoshida M, Nosaka K, Yasunaga J, Nishikata I, Morishita K, Matsuoka M.
Blood 103(7):2753-60. Epub 2003 Dec 4. 2004
25PRDM16
A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation.
Nishikata I, Sasaki H, Iga M, Tateno Y, Imayoshi S, Asou N, Nakamura T, Morishita K.
Blood 102(9):3323-32. Epub 2003 Jun 19. 2003
26PRDM16
A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 geneand is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells.
Mochizuki N, Shimizu S, Nagasawa T, Tanaka H, Taniwaki M, Yokota J,Morishita K.
Blood 96(9):3209-14. 2000
27ACAP3, AMBRA1, CMIP, CNTNAP3, CNTNAP4, CPEB4, DAB2IP, DDHD1, DISP2, EEPD1, EXOC4, FAM40A, HELZ2, ITPRIP, KIAA1683, KIAA1712, KIAA1715, KIAA1737, KIAA1751, KIAA1755, KIF21A, MTMR12, PHACTR1, PHF21A, PRDM16, RAPH1, RHOXF1, SEMA4B, SEMA4C, SET7, SH3BP5L, SPHKAP, SSH2, TET1, TEX2, TNKS1BP1, UBE2O, UNC13A, UNK, WNK2, ZCCHC2, ZFHX2, ZNF407, ZNF436
Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.
Nagase T, Kikuno R, Hattori A, Kondo Y, Okumura K, Ohara O.
DNA Res 7(6):347-55. 2000
28PRDM5, PRDM7, PRDM6, PRDM14, PRDM11, PRDM12, PRDM13, PRDM16, PRDM8, PRDM9
The yin-yang of PR-domain family genes in tumorigenesis.
Jiang GL, Huang S.
Histol Histopathol 15(1):109-17. Review. 2000